Crossiellidines A-F, Unprecedented Pyrazine-Alkylguanidine Metabolites with Broad-Spectrum Antibacterial Activity from Crossiella sp.

Francisco Javier Ortiz-López*, Daniel Oves-Costales, Daniel Carretero-Molina, Jesús Martín, Caridad Díaz, Mercedes de la Cruz, Fernando Román-Hurtado, María Álvarez-Arévalo, Tue Sparholt Jørgensen, Fernando Reyes, Tilmann Weber, Olga Genilloud*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Abstract

Crosiellidines are intriguing pyrazine-alkylguanidine metabolites isolated from the minor actinomycete genus Crossiella. Their structures present an unprecedented 2-methoxy-3,5,6-trialkyl pyrazine scaffold and uncommon guanidine prenylations, including an exotic O-prenylated N-hydroxyguanidine moiety. The novel substitution pattern of the 2-methoxypyrazine core inaugurates a new class of naturally occurring pyrazine compounds, the biosynthetic implications of which are discussed herein. Isotopic feeding and genome analysis allowed us to propose a biosynthetic pathway from arginine. The crossiellidines exhibited remarkable, broad-spectrum antibacterial activity.

Original languageEnglish
JournalOrganic Letters
Volume25
Pages (from-to)3502-3507
Number of pages4
ISSN1523-7060
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Crossiellidines A-F, Unprecedented Pyrazine-Alkylguanidine Metabolites with Broad-Spectrum Antibacterial Activity from Crossiella sp.'. Together they form a unique fingerprint.

Cite this